Higher serum levels of autotaxin and phosphatidylserine-specific phospholipase A1 in patients with lupus nephritis.
Yasunori IwataShinji KitajimaJunya YamahanaShuji ShimomuraShiori Yoneda-NakagawaNorihiko SakaiKengo FuruichiHisayuki OguraKoichi SatoTadashi ToyamaYuta YamamuraTaro MiyagawaAkinori HaraMiho ShimizuRyunosuke OhkawaMakoto KuranoYutaka YatomiTakashi WadaPublished in: International journal of rheumatic diseases (2020)
Although the serum levels of ATX and PS-PLA1 were affected by the treatment, these levels were higher in the patients with LN. The potential clinical benefits of these markers need to be clarified in further studies.